In patients with pulmonary arterial hypertension (PAH) presenting with progressive disease despite optimised medical therapy, lung transplantation remains an important treatment option [1–3]. Current guidelines recommend assessing the individual mortality risk regularly using a three-stratum model to determine whether patients are at low, intermediate or high risk of death [1, 2].

中文翻译：

---

肺动脉高压的精细风险分层和肺移植时机

尽管经过优化的药物治疗，肺动脉高压 (PAH) 患者仍出现疾病进展，肺移植仍然是一种重要的治疗选择 [1-3]。目前的指南建议使用三层模型定期评估个体死亡风险，以确定患者的死亡风险是低、中还是高 [1, 2]。